Large Granular Lymphocytic Leukemia: A Treatable Form of Refractory Celiac Disease
Georgia Malamut(Délégation Paris 5), Christophe Cellier(Assistance Publique – Hôpitaux de Paris), Bertrand Meresse(Centre Hospitalier Universitaire de Lille), Nadine Cerf–Bensussan(Université Paris Cité), Gabriel Rahmi(Inserm), Julien Lenglet(Délégation Paris 5), Céline Callens(Université Paris Sciences et Lettres), Nicolas Montcuquet(Délégation Paris 5), Olivier Hermine(Centre National de la Recherche Scientifique), Elizabeth Macintyre(Inserm), Brigitte Ranque(Hôpital Européen), Sophie Kaltenbach(Assistance Publique – Hôpitaux de Paris), Isabelle Radford‐Weiss(Hôpital Necker-Enfants Malades), Virginie Verkarre(Université Paris Cité), Elia Samaha(Délégation Paris 5), Jean–Paul Duong Van Huyen(Hôpital Necker-Enfants Malades)
Cited by 28
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k